Healthcare provider profile · identity verified

Craig E Kannel, MD

Internal Medicine · WILBRAHAM, MA · NPI 1659382281

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	402	116
Lisinopril	Lisinopril	360	89
Amlodipine Besylate	Amlodipine Besylate	336	90
Omeprazole	Omeprazole	329	83
Levothyroxine Sodium	Levothyroxine Sodium	320	72
Pravastatin Sodium	Pravastatin Sodium	309	81
Atorvastatin Calcium	Atorvastatin Calcium	298	84
Lorazepam	Lorazepam	183	39
Tamsulosin Hcl	Tamsulosin Hcl	169	45
Duloxetine Hcl	Duloxetine Hcl	164	38
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	161	44
Metformin Hcl	Metformin Hcl	155	46
Gabapentin	Gabapentin	144	35
Oxycodone Hcl	Oxycodone Hcl	141	35
Metoprolol Succinate	Metoprolol Succinate	137	42
Escitalopram Oxalate	Escitalopram Oxalate	136	37
Fluticasone Propionate	Fluticasone Propionate	134	54
Clonazepam	Clonazepam	132	24
Farxiga	Dapagliflozin Propanediol	127	24
Losartan Potassium	Losartan Potassium	121	32
Tramadol Hcl	Tramadol Hcl	110	27
Sertraline Hcl	Sertraline Hcl	104	26
Eliquis	Apixaban	99	23
Metformin Hcl Er	Metformin Hcl	99	25
Zolpidem Tartrate	Zolpidem Tartrate	90	17
Valsartan	Valsartan	87	24
Hydrochlorothiazide	Hydrochlorothiazide	83	20
Famotidine	Famotidine	82	20
Alendronate Sodium	Alendronate Sodium	80	17
Montelukast Sodium	Montelukast Sodium	77	22
Trazodone Hcl	Trazodone Hcl	77	22
Pantoprazole Sodium	Pantoprazole Sodium	76	22
Metoprolol Tartrate	Metoprolol Tartrate	69	17
Furosemide	Furosemide	66	17
Bupropion Xl	Bupropion Hcl	65	17
Atenolol	Atenolol	64	14
Indapamide	Indapamide	61	17
Allopurinol	Allopurinol	59	16
Albuterol Sulfate Hfa	Albuterol Sulfate	57	26
Ozempic	Semaglutide	56	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	12
Fluoxetine Hcl	Fluoxetine Hcl	55	11
Venlafaxine Hcl Er	Venlafaxine Hcl	53	suppressed
Jardiance	Empagliflozin	50	13
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	49	13
Irbesartan	Irbesartan	49	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	16
Mirtazapine	Mirtazapine	48	15
Potassium Chloride	Potassium Chloride	48	11
Chlorthalidone	Chlorthalidone	47	13
Diclofenac Sodium	Diclofenac Sodium	47	15
Trulicity	Dulaglutide	43	suppressed
Baclofen	Baclofen	40	suppressed
Ezetimibe	Ezetimibe	40	12
Finasteride	Finasteride	40	suppressed
Lamotrigine	Lamotrigine	40	suppressed
Celecoxib	Celecoxib	39	18
Nortriptyline Hcl	Nortriptyline Hcl	37	suppressed
Ibuprofen	Ibuprofen	36	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	12
Morphine Sulfate Er	Morphine Sulfate	34	suppressed
Benazepril Hcl	Benazepril Hcl	33	suppressed
Diazepam	Diazepam	33	suppressed
Risperidone	Risperidone	32	suppressed
Simvastatin	Simvastatin	32	12
Metoclopramide Hcl	Metoclopramide Hcl	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	27
Synthroid	Levothyroxine Sodium	30	suppressed
Fluocinonide	Fluocinonide	29	15
Naproxen	Naproxen	28	13
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	26	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Methylprednisolone	Methylprednisolone	25	18
Amoxicillin	Amoxicillin	24	15
Xarelto	Rivaroxaban	24	suppressed
Alprazolam	Alprazolam	23	11
Donepezil Hcl	Donepezil Hcl	23	suppressed
Hydrocodone-Ibuprofen	Hydrocodone/Ibuprofen	23	suppressed
Lidocaine	Lidocaine	23	suppressed
Prednisone	Prednisone	23	14
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Gemfibrozil	Gemfibrozil	21	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Verapamil Er Pm	Verapamil Hcl	19	suppressed
Carvedilol	Carvedilol	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Ramipril	Ramipril	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Lactulose	Lactulose	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Felodipine Er	Felodipine	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Galantamine Hbr	Galantamine Hbr	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Azithromycin	Azithromycin	13	11
Betamethasone Dipropionate	Betamethasone Dipropionate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Zenpep	Lipase/Protease/Amylase	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Wegovy	Semaglutide	12	suppressed
Estradiol	Estradiol	11	suppressed
Euthyrox	Levothyroxine Sodium	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Naloxone Hcl	Naloxone Hcl	11	11
Oxcarbazepine	Oxcarbazepine	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error